Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ArteriA Medical Science

ArteriA Medical Science
1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of medical technologies with applications in stroke diagnosis, prevention, and treatment. The company's stroke prevention and treatment technologies provide total embolic protection during percutaneous intervention, protects before lesion is touched and until procedure is complete, Parodi catheter controls the contrast fluid in the target vessel, provides accurate definition of the lesion with minimal contrast fluid and the therapy removes thrombus emboli from the brain and controls direction of blood flow in the brain.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Therapeutic Devices
Diagnostic Equipment
Acquirer
W. L. Gore and Associates
Primary Office
  • PO Box 29448
  • San Francisco, CA 94129
  • United States

ArteriA Medical Science Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ArteriA Medical Science‘s full profile, request access.

Request full access to PitchBook

ArteriA Medical Science Executive Team (2)

Name Title Board
Seat
Contact
Info
Gerald Sanders Chief Executive Officer & Board Member
Franci Fridell Chief Financial Officer

ArteriA Medical Science Board Members (1)

Name Representing Role Since Contact
Info
000000 0000000 ArteriA Medical Science Chief Executive Officer & Board Member 000 0000